We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Genes Found on Chromosome 21

By Biotechdaily staff writers
Posted on 02 Jul 2002
Use of refined analytical techniques has revealed that human chromosome 21 contains roughly 10% more genes than were previously either predicted or confirmed. More...
The missing genes were likely not identified before because they are small and encode small proteins. This finding is reported in the June 2002 issue of Genomics.

"This demonstrates why we cannot rely on gene prediction alone to identify all human genes,” said the study's lead author, Dr. Stylianos Antonarakis of the University of Geneva Medical School (Switzerland). "Getting the right number of genes is crucial if we hope to use this information to fight disease.”

The initial DNA sequence of chromosome 21 showed 127 known genes, and another 98 were predicted. In the current study, researchers analyzed chromosome 21 through a strategy that compares the genome sequence with experimental data generated from expressed sequence tags (ESTs). Taken from various tissues or cell types, EST transcripts provide strong evidence that a portion of the genome is actually expressed and functions as a gene. This approach identified a number of suspected new genes on chromosome 21. Further analytical tests including gene mapping confirmed this data. All told, the researchers identified 163 genes known to exist on chromosome 21 while discovering 19 new ones.

"The initial "road map” of the human genome has been extraordinarily important for pointing everyone in the right direction, but we are finding a lot of room for errors,” said Dr. Antonarakis. "A more accurate map will require a gene-by-gene search that needs to be followed up with thorough testing.”



Related Links:
University of Geneva Medical School

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.